Compare ARK Genomic Revolution ETF (ARKG) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Skyworks Solutions Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Skyworks Solutions Inc trades at $59.51 (market cap $9.08B). The key difference: Skyworks Solutions Inc pays a 4.7% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Skyworks Solutions Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | SWKS | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $83.40 |
52-Week Low | $23.09 | $52.50 |
Market Cap | — | $9.08B |
Enterprise Value | — | $8.85B |
Dividend Yield | — | 4.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SWKS trades at $60.36, up 0.68% on the day, with a bearish technical signal but bullish oscillators. The company reported Q1 2026 EPS of $1.15, beating estimates, and maintains a dividend. Revenue has trended down from $5.5B in 2022 to $4.1B in 2025, though net income margin remains positive at 8.93%. Recent news highlights potential in smartphone chips and AI infrastructure.
The outlook is mixed: strong analyst buy consensus (60%) and a $72.56 price target suggest upside, but declining revenue, legal investigations, and a bearish technical trend pose risks. The stock's valuation at a P/E of 25.16 appears reasonable if growth stabilizes, but investor caution is warranted amid competitive and execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
